1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > North American Intrauterine Contraceptive Devices Market by Type - Forecast to 2019

North American Intrauterine Contraceptive Devices Market by Type - Forecast to 2019

  • February 2015
  • -
  • Micro Market Monitor
  • -
  • 70 pages

Summary

Table of Contents

Search Inside

The North America intrauterine contraceptive devices market is estimated to grow at a CAGR of 0.3% from 2014 to 2019. The growth of the intrauterine contraceptive devices market is driven by factors such as increasing rate of unplanned pregnancies, effective contraception and less side effects of IUCD, implementation of the Affordable Care Act (ACA), rising initiatives of private firms directed towards reducing expenses related to abortion, funds/grants for IUCD products, and technological advancements. However, high costs of treatment, threat of pelvic inflammatory infection (PID), threat of ectopic pregnancy, high rate of complications during unplanned pregnancy, and the need for compulsory assistance of medical professionals hamper the growth of the IUCD market. Moreover, the rising number of players in this segment and technological advancements create growth opportunities for the North America intrauterine contraceptive devices market in these regions.

In this report, the North America intrauterine contraceptive devices market has been broadly classified on the basis of types, which includes Hormonal IUCD and Copper IUCD. The hormonal IUCD market segment accounted for the largest market share of 83.4% of the North American intrauterine contraceptive devices market. Factors such as safety, easy removal, lighter periods, and the increasing adoption of hormonal IUD products such as Mirean and Skyla in the U.S. drive the growth of this market.

Geographically, the U.S. is estimated to command the largest share of 93.0% of the North America intrauterine contraceptive devices market in 2014, followed by Canada. The intrauterine contraceptive devices market in the U.S. is primarily driven by the Affordable Care Act and technological advancements. However, stringent regulatory and reimbursement policies in the U.S. and the threat of PID infection hamper the growth of the intrauterine contraceptive devices market in this region.

The North America intrauterine contraceptive devices market is a competitive market with a number of market players. As of 2014, the North America intrauterine contraceptive devices market is estimated to be dominated by Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland). New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the North America intrauterine contraceptive devices market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging- and high-growth segments of the North America intrauterine contraceptive devices market, high-growth regions & countries & their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both the established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on intrauterine contraceptive devices offered by top players in the North America intrauterine contraceptive devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the North America intrauterine contracep

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Contraceptives - Consumer Healthcare

Global Contraceptives - Consumer Healthcare

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Contraceptives in US$ by the following Contraception Methods: Hormonal Contraceptives (Oral Contraceptives, & Other Hormonal Contraceptives), and Condoms. ...

Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts (2017 - 2022)

Global Intrauterine Contraceptive Devices Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4750
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The Global Intra Uterine contraceptive Devices market is estimated to be USD 1,370 million in 2016 and is expected to reach USD 2,267 million by 2021, growing at a compound annual growth rate (CAGR) of ...

Global Contraceptive Pills Market - Growth, Trends and Forecasts (2017 - 2022)

Global Contraceptive Pills Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global market for contraceptive pills is estimated to be USD 680 million in the year 2014. This market is expected to reach USD 1.03 billion by the end of 2019. During this period, the market is estimated ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    28 pages
  • Therapy  

  • United States  

View report >

Biguanide Market in India

  • April 2017
    3 pages
  • Biguanide  

    Dermatological ...  

  • India  

View report >

Therapy Market in the US

  • March 2017
    265 pages
  • Therapy  

    Cardiovascular ...  

    Risky Behaviour  

  • United States  

View report >

Related Market Segments :

Contraceptive
Pharmaceutical
Healthcare

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.